Filter by Interests
Filter by ContentType
Preparing for success in gene therapy purification
X Fu, A Sharma, A D Tustian et al
05 December 2024
Expert Roundtable
Preparing for success in gene therapy analytical development
Yan Zhi, Jing Li, Andres Castillo
02 December 2024
Expert Roundtable
Fast-tracking gene therapy breakthroughs: discussing the critical role of rapid testing
R Legmann, G Thakur, S Levy et al
05 January 2024
Expert Roundtable
Navigating evolving regulatory CMC guidance in the AAV gene therapy field
M Brewer, A Cockroft, C Fuentes et al
15 May 2023
Expert Roundtable
Driving the expansion of mRNA into the therapeutic sphere
Alejandro Becerra, Andreas Kuhn, Metin Kurtoglu
10 April 2023
Expert Roundtable
AAV process development & scale-up
Catherine Cancian, Karen Doucette, Reinout Hesselink
07 March 2023
Expert Roundtable
Strategies for scaling up and out in gene therapy manufacturing: addressing AAV’s growing pains
Christopher Reardon, Phillip Vermilion, John Yoshi Shyu
22 March 2022
Expert Roundtable
A ddPCR primer: advantages, challenges, and key considerations when adopting Droplet Digital PCR for viral vector manufacture
L M Drouin, F Dorange, B Silvey et al
13 December 2021
Expert Roundtable
Expert Roundtable: accelerating time to market for CAR-T cell therapies through translatable workflow
Tariq Haq
22 November 2021
Expert Roundtable
Expert Roundtable: evolution in AAV process development: 2022 and beyond
Matthias Hebben
13 October 2021
Expert Roundtable
Expert Roundtable: analytical tools for cell and gene therapy: what’s new and what’s next?
Sarah Snykers, Andrea Moore, Tony Bou Kheir
26 September 2021
Expert Roundtable
Viral vector production process intensification: analytics, automation, in-line testing and more
09 February 2021
Expert Roundtable
Streamlining and optimizing viral vector bioprocess and analytical development
J Tarnowski, N Kotsopoulou, K Patel et al
19 January 2021
Expert Roundtable
Expert Roundtable: getting a gene therapy product to market: pitfalls and how to prevent them
Hetal Brahmbhatt, Thomas Guarinoni, Elizabeth Simmons
29 September 2020
Expert Roundtable
Scale-up considerations for improved yield in upstream viral vector production
S Ansorge, M Burnham, M Kelly et al
05 February 2020
Expert Roundtable
AAV vector process development: achieving high purity and high yield – experiences from the frontline
M Bakhshayeshi, M Mercaldi, M Hebben et al
07 June 2019
Expert Roundtable